Screener Summaries Updates Institutions Sign In More Updates › Financing › CELC Financing · Jun 8, 2026
Celcuity Inc. completed the issuance of $575,000,000 in 0.250% Convertible Senior Notes due 2032, generating… CELC Celcuity Inc.
Celcuity Inc. completed the issuance of $575,000,000 in 0.250% Convertible Senior Notes due 2032, generating approximately $557.0 million in net proceeds. The company also completed a voluntary prepayment of approximately $137.5 million to satisfy and discharge in full all outstanding obligations under its existing Loan Agreement.
More from Celcuity Inc. Reports Q3 net loss of $73.3M as REVTORPYK launches; Byron Robinson joins as CSO Nov 5, 2026 Celcuity appoints David W. Gryska to its Board with $100K equity award Oct 2, 2026 Celcuity launches REVTORPYK in the US for breast cancer; drug cuts progression risk by up to 76% Sep 30, 2026 On August 26, 2026, Celcuity Inc. submitted a supplemental New Drug Application to the U.S. Food and Drug… Aug 26, 2026 Celcuity Inc. reported financial results for the quarter ended June 30, 2026, posting a net loss of $78.9 million, or… Aug 13, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
